{
    "Trade/Device Name(s)": [
        "mecA XpressFISH",
        "mecA PNA FISH"
    ],
    "Submitter Information": "AdvanDx, Inc.",
    "510(k) Number": "K140619",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090301"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYI"
    ],
    "Summary Letter Date": "September 8, 2014",
    "Summary Letter Received Date": "September 9, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "mecA mRNA"
    ],
    "Specimen Type(s)": [
        "Blood culture (positive for Staphylococcus aureus)"
    ],
    "Specimen Container(s)": [
        "Blood culture bottle"
    ],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Fluorescence in situ hybridization (FISH)",
        "Peptide nucleic acid (PNA) probe hybridization"
    ],
    "Methodologies": [
        "Molecular detection of gene expression",
        "FISH"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Control",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for AdvanDx mecA XpressFISH qualitative FISH assay for detecting mecA mRNA from MRSA in S. aureus positive blood cultures",
    "Indications for Use Summary": "Qualitative nucleic acid FISH assay for detecting mecA mRNA in smears from blood cultures positive for S. aureus by Staphylococcus QuickFISH BC, used with other tests and clinical data to aid detection of mecA mRNA from MRSA in patient blood cultures; not for monitoring treatment or use with mixed cultures.",
    "fda_folder": "Microbiology"
}